Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3

Watchlist Manager
Profarma Distribuidora de Produtos Farmaceuticos SA Logo
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
Watchlist
Price: 8.3 BRL 1.34% Market Closed
Market Cap: 1B BRL

Intrinsic Value

The intrinsic value of one PFRM3 stock under the Base Case scenario is 22.2 BRL. Compared to the current market price of 8.3 BRL, Profarma Distribuidora de Produtos Farmaceuticos SA is Undervalued by 63%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PFRM3 Intrinsic Value
22.2 BRL
Undervaluation 63%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Profarma Distribuidora de Produtos Farmaceuticos SA

Compare PFRM3 to

Fundamental Analysis

Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
BR
Health Care
Market Cap
1B BRL
IPO
Oct 26, 2006
BR
Health Care
Market Cap
1B BRL
IPO
Oct 26, 2006
Price
R$false
EPS
R$false
Profarma Distribuidora de Produtos Farmaceuticos SA
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PFRM3?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Profarma Distribuidora de Produtos Farmaceuticos SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Profarma Distribuidora de Produtos Farmaceuticos SA

Current Assets 4.2B
Cash & Short-Term Investments 270.6m
Receivables 2B
Other Current Assets 1.9B
Non-Current Assets 1.6B
Long-Term Investments 5.9m
PP&E 710.9m
Intangibles 628.1m
Other Non-Current Assets 268.9m
Efficiency

Free Cash Flow Analysis
Profarma Distribuidora de Produtos Farmaceuticos SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Profarma Distribuidora de Produtos Farmaceuticos SA

Revenue
10.6B BRL
Cost of Revenue
-9B BRL
Gross Profit
1.6B BRL
Operating Expenses
-1.3B BRL
Operating Income
304.1m BRL
Other Expenses
-179.6m BRL
Net Income
124.5m BRL
Fundamental Scores

PFRM3 Profitability Score
Profitability Due Diligence

Profarma Distribuidora de Produtos Farmaceuticos SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
ROE is Increasing
ROIC is Increasing
Sustainable 3Y Average Gross Margin
48/100
Profitability
Score

Profarma Distribuidora de Produtos Farmaceuticos SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

PFRM3 Solvency Score
Solvency Due Diligence

Profarma Distribuidora de Produtos Farmaceuticos SA's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
42/100
Solvency
Score

Profarma Distribuidora de Produtos Farmaceuticos SA's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PFRM3 Price Targets Summary
Profarma Distribuidora de Produtos Farmaceuticos SA

There are no price targets for PFRM3.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PFRM3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PFRM3 stock?

The intrinsic value of one PFRM3 stock under the Base Case scenario is 22.2 BRL.

Is PFRM3 stock undervalued or overvalued?

Compared to the current market price of 8.3 BRL, Profarma Distribuidora de Produtos Farmaceuticos SA is Undervalued by 63%.

Back to Top